BIO-RAD LABORATORIES, INC.

BIO-RAD LABORATORIES, INC. (CIK 12208) is a stalwart in the medical instruments SIC 3841 ecosystem, producing diagnostics, life‑science research tools, and quality‑control reagents that support biotech firms, clinical labs, and academic research centers worldwide; the company’s mix of advanced instruments and consumables, including PCR systems and chromatography platforms, caters to scientists tracking disease markers, therapeutics developers, and hospitals that must meet stringent testing demands. Public disclosure is light right now, with the latest filing yet to be posted, though BIOTECH’s SEC cadence is shaped by FDA oversight, export controls, and evolving reimbursement rules that add material regulatory risk to any new product launch or clinical supply agreement. Investors should watch the impact of biotech funding cycles, supply-chain disruptions, and compliance with laboratory safety standards, as these factors drive revenue visibility and pricing flexibility for BIO. View live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025